[Form 4] The Beauty Health Company Insider Trading Activity
The Beauty Health Company (SKIN) Form 4 reports a non-sale withholding of shares by Chief Financial Officer Michael P. Monahan related to the vesting of restricted stock units. On 08/10/2025, 32,357 shares were withheld to satisfy tax withholding at a recorded price of $1.89 per share. The disclosure states this withholding "does not represent a sale." Following the transaction, the reporting person’s beneficial ownership is shown as 1,326,305 shares.
This filing documents an internal compensation settlement (tax withholding on vested RSUs) rather than an open-market transaction, and it clarifies the officer’s post-transaction share count.
Il Form 4 di The Beauty Health Company (SKIN) segnala una ritenuta di azioni non derivante da una vendita da parte del Chief Financial Officer Michael P. Monahan, relativa alla maturazione di unità azionarie vincolate (RSU). Il 08/10/2025 sono state trattenute 32,357 azioni per soddisfare la ritenuta fiscale al prezzo registrato di $1.89 per azione. La comunicazione specifica che questa ritenuta "non rappresenta una vendita". Dopo l'operazione, la proprietà beneficiaria del dichiarante risulta essere 1,326,305 azioni.
Questa segnalazione documenta un regolamento interno di compensi (ritenuta fiscale sulle RSU maturate) e non una transazione sul mercato aperto, e chiarisce il numero di azioni detenute dal dirigente dopo l'operazione.
El Formulario 4 de The Beauty Health Company (SKIN) reporta una retención de acciones que no es una venta por parte del Chief Financial Officer Michael P. Monahan, relacionada con el vesting de unidades de acciones restringidas (RSU). El 08/10/2025 se retuvieron 32,357 acciones para cubrir la retención fiscal a un precio registrado de $1.89 por acción. La divulgación indica que esta retención "no representa una venta". Tras la operación, la propiedad beneficiaria del declarante se muestra como 1,326,305 acciones.
Este registro documenta un ajuste interno de compensación (retención fiscal sobre RSU ya vestidas) más que una transacción en el mercado abierto, y aclara el conteo de acciones del ejecutivo tras la operación.
The Beauty Health Company (SKIN)의 Form 4 보고서에 따르면 재무책임자(Chief Financial Officer) Michael P. Monahan이 제한부 주식 단위(RSU)의 베스팅과 관련해 매각이 아닌 형태로 주식을 원천징수했습니다. 08/10/2025에 32,357주가 세금 원천징수를 충당하기 위해 차감되었으며, 기록된 주당 가격은 $1.89였습니다. 공시에는 이 원천징수가 "판매를 의미하지 않는다"고 명시되어 있습니다. 거래 후 보고자의 실소유 주식 수는 1,326,305주로 표시됩니다.
이 제출은 공개시장 거래가 아닌 내부 보상 정산(베스팅된 RSU에 대한 세금 원천징수)을 문서화한 것이며, 임원 거래 후 주식 수를 명확히 합니다.
Le formulaire 4 de The Beauty Health Company (SKIN) indique une retenue d'actions qui ne constitue pas une vente effectuée par le directeur financier Michael P. Monahan, liée au vesting d'unités d'actions restreintes (RSU). Le 08/10/2025, 32,357 actions ont été retenues pour couvrir la retenue fiscale à un prix enregistré de $1.89 par action. La déclaration précise que cette retenue "ne représente pas une vente". Après la transaction, la participation bénéficiaire de la personne déclarante est indiquée à 1,326,305 actions.
Ce dépôt documente un règlement interne de rémunération (retenue fiscale sur les RSU acquis) plutôt qu'une transaction sur le marché ouvert, et il précise le nombre d'actions détenues par le dirigeant après la transaction.
Das Formular 4 von The Beauty Health Company (SKIN) berichtet über eine einbehaltene Aktienmenge, die keine Veräußerung darstellt, durch Chief Financial Officer Michael P. Monahan im Zusammenhang mit dem Vesting von Restricted Stock Units (RSU). Am 08/10/2025 wurden 32,357 Aktien einbehalten, um die Steuerverpflichtung zu erfüllen, zu einem aufgezeichneten Preis von $1.89 je Aktie. Die Offenlegung stellt klar, dass diese Einbehaltung "keinen Verkauf darstellt". Nach der Transaktion wird der wirtschaftliche Besitz der meldenden Person mit 1,326,305 Aktien angegeben.
Diese Meldung dokumentiert eine interne Vergütungsabrechnung (Steuereinbehalt auf vested RSU) und nicht eine Transaktion am offenen Markt, und sie macht die Anzahl der Aktien des Vorstandsmitglieds nach der Transaktion deutlich.
- Non-sale clarity: The filing explicitly states the 32,357 shares were withheld for tax withholding on vested RSUs and "does not represent a sale."
- Post-transaction ownership disclosed: Beneficial ownership after the transaction is reported as 1,326,305 shares, providing clear transparency.
- None.
Insights
TL;DR: Routine insider withholding for RSU taxes; not a market sale; beneficial ownership reported at 1,326,305 shares.
The Form 4 filed for Michael P. Monahan, Chief Financial Officer, records a transaction dated 08/10/2025 in which 32,357 shares were withheld to satisfy tax withholding obligations on vesting restricted stock units. The document explicitly states the withholding is not a sale. The withholding is recorded at $1.89 per share and the reporting person’s beneficial ownership after the transaction is 1,326,305 shares. From a financial reporting perspective, this is a compensation-related mechanical adjustment to insider holdings rather than a liquidity event.
TL;DR: Disclosure indicates executive RSU vesting settled via share withholding; procedural governance activity with no indicated disposition.
The Form 4 shows Michael P. Monahan’s vested restricted stock units were settled by withholding 32,357 shares for tax purposes. The filing uses transaction code F and includes an explicit explanation that the withheld shares do not represent a sale. The form reports the resulting beneficial ownership level of 1,326,305 shares. This disclosure fulfills Section 16 reporting requirements for an officer compensation event and documents the change in share count attributable to tax withholding.
Il Form 4 di The Beauty Health Company (SKIN) segnala una ritenuta di azioni non derivante da una vendita da parte del Chief Financial Officer Michael P. Monahan, relativa alla maturazione di unità azionarie vincolate (RSU). Il 08/10/2025 sono state trattenute 32,357 azioni per soddisfare la ritenuta fiscale al prezzo registrato di $1.89 per azione. La comunicazione specifica che questa ritenuta "non rappresenta una vendita". Dopo l'operazione, la proprietà beneficiaria del dichiarante risulta essere 1,326,305 azioni.
Questa segnalazione documenta un regolamento interno di compensi (ritenuta fiscale sulle RSU maturate) e non una transazione sul mercato aperto, e chiarisce il numero di azioni detenute dal dirigente dopo l'operazione.
El Formulario 4 de The Beauty Health Company (SKIN) reporta una retención de acciones que no es una venta por parte del Chief Financial Officer Michael P. Monahan, relacionada con el vesting de unidades de acciones restringidas (RSU). El 08/10/2025 se retuvieron 32,357 acciones para cubrir la retención fiscal a un precio registrado de $1.89 por acción. La divulgación indica que esta retención "no representa una venta". Tras la operación, la propiedad beneficiaria del declarante se muestra como 1,326,305 acciones.
Este registro documenta un ajuste interno de compensación (retención fiscal sobre RSU ya vestidas) más que una transacción en el mercado abierto, y aclara el conteo de acciones del ejecutivo tras la operación.
The Beauty Health Company (SKIN)의 Form 4 보고서에 따르면 재무책임자(Chief Financial Officer) Michael P. Monahan이 제한부 주식 단위(RSU)의 베스팅과 관련해 매각이 아닌 형태로 주식을 원천징수했습니다. 08/10/2025에 32,357주가 세금 원천징수를 충당하기 위해 차감되었으며, 기록된 주당 가격은 $1.89였습니다. 공시에는 이 원천징수가 "판매를 의미하지 않는다"고 명시되어 있습니다. 거래 후 보고자의 실소유 주식 수는 1,326,305주로 표시됩니다.
이 제출은 공개시장 거래가 아닌 내부 보상 정산(베스팅된 RSU에 대한 세금 원천징수)을 문서화한 것이며, 임원 거래 후 주식 수를 명확히 합니다.
Le formulaire 4 de The Beauty Health Company (SKIN) indique une retenue d'actions qui ne constitue pas une vente effectuée par le directeur financier Michael P. Monahan, liée au vesting d'unités d'actions restreintes (RSU). Le 08/10/2025, 32,357 actions ont été retenues pour couvrir la retenue fiscale à un prix enregistré de $1.89 par action. La déclaration précise que cette retenue "ne représente pas une vente". Après la transaction, la participation bénéficiaire de la personne déclarante est indiquée à 1,326,305 actions.
Ce dépôt documente un règlement interne de rémunération (retenue fiscale sur les RSU acquis) plutôt qu'une transaction sur le marché ouvert, et il précise le nombre d'actions détenues par le dirigeant après la transaction.
Das Formular 4 von The Beauty Health Company (SKIN) berichtet über eine einbehaltene Aktienmenge, die keine Veräußerung darstellt, durch Chief Financial Officer Michael P. Monahan im Zusammenhang mit dem Vesting von Restricted Stock Units (RSU). Am 08/10/2025 wurden 32,357 Aktien einbehalten, um die Steuerverpflichtung zu erfüllen, zu einem aufgezeichneten Preis von $1.89 je Aktie. Die Offenlegung stellt klar, dass diese Einbehaltung "keinen Verkauf darstellt". Nach der Transaktion wird der wirtschaftliche Besitz der meldenden Person mit 1,326,305 Aktien angegeben.
Diese Meldung dokumentiert eine interne Vergütungsabrechnung (Steuereinbehalt auf vested RSU) und nicht eine Transaktion am offenen Markt, und sie macht die Anzahl der Aktien des Vorstandsmitglieds nach der Transaktion deutlich.
FAQ
What transaction did Michael P. Monahan report on the Form 4 for SKIN?
When was the transaction recorded on the Form 4?
What price is listed for the withheld shares on the Form 4?
How many shares does the reporting person beneficially own after the transaction?
What is Michael P. Monahan’s role at Beauty Health Co as shown on the form?
